Table 1 Baseline patients’ and treatment characteristics
Age: | |
- Median (years) | 68 |
- Range (years) | 54–82 |
PSA: | |
- Median (ng/ml) | 6.8 |
- Range (ng/ml) | 1–19 |
Class of Risk: | |
- Low | 4 (16%) |
- Favorable Intermediate | 11 (44%) |
- Unfavorable Intermediate | 10 (40%) |
Androgen deprivation therapy: | |
- Yes | 9 (36%) |
- No | 16 (64%) |
Prostate Volume: | |
- Median (cc) | 36 |
- Range (cc) | 20–61 |
IPSS score: | |
- Median | 5 |
- Range | 0–15 |
Overall Treatment Time: | |
- Median (minutes) | 41 |
- Range (minutes) | 20–61 |